FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130255055> ?p ?o ?g. }

• W2130255055 endingPage "52" @default.
• W2130255055 startingPage "1048" @default.
• W2130255055 abstract "Drug targeting through the brain capillary endothelium, which forms the blood-brain barrier (BBB) in vivo, may be achieved with peptidomimetic monoclonal antibodies that target peptide transcytosis systems on the BBB in vivo. Murine monoclonal antibodies to the rat transferrin receptor, such as the OX26 monoclonal antibody, are targeted through the BBB on the transferrin receptor in the rat. However, the present studies show the OX26 monoclonal antibody is not an effective brain delivery vector in mice. The emergence of transgenic mouse models creates a need for brain drug-targeting vectors for this species. Two rat monoclonal antibodies, 8D3 and RI7-217, to the mouse transferrin receptor were evaluated in the present studies. Both the RI7-217 and the 8D3 antibody had comparable permeability-surface area products at the mouse BBB in vivo. However, owing to a higher plasma area under the concentration curve, the mouse brain uptake of the 8D3 antibody was higher, 3.1 +/- 0.4% of injected dose [(ID)/g] compared with the brain uptake of the RI7 antibody, 1.6 +/- 0.2% ID/g, at 60 min after i.v. injection. Conversely, the mouse brain uptake of the OX26 antibody, which does not recognize the mouse transferrin receptor, was negligible, 0.06 +/- 0.01% ID/g. The RI7-127 antibody was more selective for brain because this antibody was not measureably taken up by liver. The capillary depletion technique demonstrated transcytosis of the RI7-217 antibody through the mouse BBB in vivo. The brain uptake of the 8D3 antibody was saturable, consistent with a receptor-mediated transport process. In conclusion, these studies indicate rat monoclonal antibodies to the mouse transferrin receptor may be used for brain drug-targeting studies in mice such as transgenic mouse models." @default.
• W2130255055 created "2016-06-24" @default.
• W2130255055 creator A5000308279 @default.
• W2130255055 creator A5006863443 @default.
• W2130255055 creator A5069271331 @default.
• W2130255055 creator A5075893557 @default.
• W2130255055 creator A5082705765 @default.
• W2130255055 date "2000-03-01" @default.
• W2130255055 modified "2023-10-17" @default.
• W2130255055 title "Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse." @default.
• W2130255055 cites W1505773153 @default.
• W2130255055 cites W1516338367 @default.
• W2130255055 cites W1560180952 @default.
• W2130255055 cites W176676541 @default.
• W2130255055 cites W1872613740 @default.
• W2130255055 cites W1948951149 @default.
• W2130255055 cites W1964186713 @default.
• W2130255055 cites W1986144289 @default.
• W2130255055 cites W2001867528 @default.
• W2130255055 cites W2027170943 @default.
• W2130255055 cites W2033694868 @default.
• W2130255055 cites W2037341813 @default.
• W2130255055 cites W2038300452 @default.
• W2130255055 cites W2078004577 @default.
• W2130255055 cites W2088789369 @default.
• W2130255055 cites W2091436050 @default.
• W2130255055 cites W2095512576 @default.
• W2130255055 cites W2110569992 @default.
• W2130255055 cites W2134904664 @default.
• W2130255055 cites W2160428452 @default.
• W2130255055 cites W2195417116 @default.
• W2130255055 cites W2239787143 @default.
• W2130255055 cites W2261912426 @default.
• W2130255055 cites W2409268255 @default.
• W2130255055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10688622" @default.
• W2130255055 hasPublicationYear "2000" @default.
• W2130255055 type Work @default.
• W2130255055 sameAs 2130255055 @default.
• W2130255055 citedByCount "76" @default.
• W2130255055 countsByYear W21302550552012 @default.
• W2130255055 countsByYear W21302550552013 @default.
• W2130255055 countsByYear W21302550552014 @default.
• W2130255055 countsByYear W21302550552015 @default.
• W2130255055 countsByYear W21302550552016 @default.
• W2130255055 countsByYear W21302550552017 @default.
• W2130255055 countsByYear W21302550552018 @default.
• W2130255055 countsByYear W21302550552019 @default.
• W2130255055 countsByYear W21302550552020 @default.
• W2130255055 countsByYear W21302550552021 @default.
• W2130255055 countsByYear W21302550552022 @default.
• W2130255055 countsByYear W21302550552023 @default.
• W2130255055 crossrefType "journal-article" @default.
• W2130255055 hasAuthorship W2130255055A5000308279 @default.
• W2130255055 hasAuthorship W2130255055A5006863443 @default.
• W2130255055 hasAuthorship W2130255055A5069271331 @default.
• W2130255055 hasAuthorship W2130255055A5075893557 @default.
• W2130255055 hasAuthorship W2130255055A5082705765 @default.
• W2130255055 hasConcept C102230213 @default.
• W2130255055 hasConcept C104317684 @default.
• W2130255055 hasConcept C134018914 @default.
• W2130255055 hasConcept C141035611 @default.
• W2130255055 hasConcept C150903083 @default.
• W2130255055 hasConcept C153911025 @default.
• W2130255055 hasConcept C159654299 @default.
• W2130255055 hasConcept C170493617 @default.
• W2130255055 hasConcept C185350488 @default.
• W2130255055 hasConcept C185592680 @default.
• W2130255055 hasConcept C203014093 @default.
• W2130255055 hasConcept C207001950 @default.
• W2130255055 hasConcept C22814914 @default.
• W2130255055 hasConcept C2778402981 @default.
• W2130255055 hasConcept C28005876 @default.
• W2130255055 hasConcept C32264632 @default.
• W2130255055 hasConcept C529278444 @default.
• W2130255055 hasConcept C542903549 @default.
• W2130255055 hasConcept C55493867 @default.
• W2130255055 hasConcept C86803240 @default.
• W2130255055 hasConceptScore W2130255055C102230213 @default.
• W2130255055 hasConceptScore W2130255055C104317684 @default.
• W2130255055 hasConceptScore W2130255055C134018914 @default.
• W2130255055 hasConceptScore W2130255055C141035611 @default.
• W2130255055 hasConceptScore W2130255055C150903083 @default.
• W2130255055 hasConceptScore W2130255055C153911025 @default.
• W2130255055 hasConceptScore W2130255055C159654299 @default.
• W2130255055 hasConceptScore W2130255055C170493617 @default.
• W2130255055 hasConceptScore W2130255055C185350488 @default.
• W2130255055 hasConceptScore W2130255055C185592680 @default.
• W2130255055 hasConceptScore W2130255055C203014093 @default.
• W2130255055 hasConceptScore W2130255055C207001950 @default.
• W2130255055 hasConceptScore W2130255055C22814914 @default.
• W2130255055 hasConceptScore W2130255055C2778402981 @default.
• W2130255055 hasConceptScore W2130255055C28005876 @default.
• W2130255055 hasConceptScore W2130255055C32264632 @default.
• W2130255055 hasConceptScore W2130255055C529278444 @default.
• W2130255055 hasConceptScore W2130255055C542903549 @default.
• W2130255055 hasConceptScore W2130255055C55493867 @default.
• W2130255055 hasConceptScore W2130255055C86803240 @default.
• W2130255055 hasIssue "3" @default.

• next